Dexcom Inc
DXCM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001093557
In the last 90 days, Dexcom Inc insiders filed 0 open-market purchases and 9 sales; 982 institutions reported holding it in 13F filings for Q2 2026, worth $26.0B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 12, 2026
- $30.4B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.48M in total
- 9
- 13F holdersQ2 2026, +26 vs. previous quarter
- 982
- 13F valueReported value at the end of Q2 2026
- $26.0B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $4.66B
- +15.6% year over year
- Net income, FY2025
- $836.3M
- +45.1% year over year
- Free cash flow, FY2025
- $1.08B
- +70.8% year over year
- Revenue, Q3 FY2026
- $1.34B
- +11.2% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 15.9M
- Shares sold short
- Change
- +242.5K
- +1.6% vs. previous
- Days to cover
- 2.81
- At average daily volume
Superinvestors holding DXCM, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding DXCM at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Dexcom Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2026 (view filing)7:08 PM ET | Oct 27 | 1 day | Stern SadieEVP Chief People & Culture Off | SSale | −2.56K | $78.62 | −$201.7K | −2.1%120.9K after | 10b5-1 |
| Oct 19, 2026 (view filing)6:42 PM ET | Oct 15 | 4 days | Brown Michael JonEVP Chief Legal Compliance Off | SSale | −1.70K | $85.48 | −$145.3K | −1.7%98.2K after | 10b5-1 |
| Sep 30, 2026 (view filing)4:15 PM ET | Sep 28 | 2 days | Stern SadieEVP Chief People & Culture Off | SSale | −2.56K | $86.15 | −$221.0K | −2.0%123.5K after | 10b5-1 |
| Sep 16, 2026 (view filing)4:26 PM ET | Sep 14-15 | 2 days | Augustinos NicholasDirector | SSale | −8.09K | $84.04 | −$679.8K | −21.6%29.3K after | 2 lots10b5-1 |
| Sep 16, 2026 (view filing)4:25 PM ET | Sep 15 | 1 day | Brown Michael JonEVP Chief Legal Compliance Off | SSale | −1.70K | $84.04 | −$142.9K | −1.7%99.9K after | 10b5-1 |
| Sep 14, 2026 (view filing)4:02 PM ET | Sep 10 | 4 days | Sylvain Jereme MEVP, Chief Financal Officer | SSale | −3.64K | $83.27 | −$302.9K | −2.4%146.8K after | 10b5-1 |
| Aug 28, 2026 (view filing)4:57 PM ET | Aug 27 | 1 day | Stern SadieEVP Chief People & Culture Off | SSale | −2.56K | $88.37 | −$226.7K | −2.0%126.0K after | 10b5-1 |
| Aug 24, 2026 (view filing)4:01 PM ET | Aug 20 | 4 days | Sayer Kevin RExecutive Chair | SSale | −26.8K | $90.01 | −$2.41M | −8.1%302.2K after | 3 lots10b5-1 |
| Aug 17, 2026 (view filing)4:08 PM ET | Aug 14 | 3 days | Brown Michael JonEVP Chief Legal Compliance Off | SSale | −1.70K | $91.93 | −$156.3K | −1.6%103.0K after | 10b5-1 |
| Aug 13, 2026 (view filing)4:04 PM ET | Aug 12 | 1 day | Heller Bridgette PDirector | SSale | −1.01K | $88.29 | −$89.3K | −3.3%29.6K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 982 holdersThe largest institutional positions in Dexcom Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 38,244,137 | $2.58B | 0.04% | −720,234−1.8% | Reduced |
| Vanguard Capital Management LLC | 25,209,752 | $1.70B | 0.04% | +188,791+0.8% | Added |
| Vanguard Portfolio Management LLC | 19,656,540 | $1.32B | 0.06% | +436,587+2.3% | Added |
| State Street Corp | 18,380,806 | $1.24B | 0.04% | +445,959+2.5% | Added |
| Invesco Ltd. | 15,288,133 | $1.03B | 0.08% | +1,615,819+11.8% | Added |
| Baillie Gifford & Co | 14,801,590 | $996.9M | 0.90% | −797,935−5.1% | Reduced |
| Geode Capital Management, LLC | 12,426,515 | $834.2M | 0.04% | +79,877+0.6% | Added |
| UBS Asset Management Americas Inc | 11,261,876 | $758.5M | 0.14% | +1,515,702+15.6% | Added |
| Alliancebernstein L.P. | 11,693,409 | $734.3M | 0.26% | −1,230,235−9.5% | Reduced |
| Wellington Management Group LLP | 8,527,471 | $574.3M | 0.10% | −798,769−8.6% | Reduced |
Holders of 5% or more of DXCM
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Dexcom Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 8.30%32.5M shares | – | Dec 6, 20242 filings | Apr 24, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 7.49%28.8M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G | 5.02%19.3M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| State Street Corp | 13G | 5.00%18.9M shares | New | Nov 10, 20261 filing | Nov 10, 2026 | SEC |
Politician trades
All politician trades in DXCM10 members of Congress reported 25 trades in Dexcom Inc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| May 10, 2026 |  Tina Smith Senate · MN | Sell (partial) | $100K-$250K |
| May 10, 2026 | Tina Smith Senate · MN | Sell (full) | $100K-$250K |
| Feb 15, 2026 |  John Boozman Senate · AR | Buy | $1K-$15K |
| Jun 22, 2025 |  Jefferson Shreve House · IN | Buy | $15K-$50K |
| Jun 22, 2025 | Jefferson Shreve House · IN | Sell | $15K-$50K |
Senate · MN · May 10, 2026
Sell (partial)$100K-$250K
Senate · MN · May 10, 2026
Sell (full)$100K-$250K
Senate · AR · Feb 15, 2026
Buy$1K-$15K
House · IN · Jun 22, 2025
Buy$15K-$50K
House · IN · Jun 22, 2025
Sell$15K-$50K